Revolution Medicines’ pancreatic cancer drug doubles survival time in Phase 3news2026-04-13T12:00:21+00:00April 13th, 2026|Endpoints News|
Ideaya’s uveal melanoma drug exceeds success benchmark in late-stage trialnews2026-04-13T10:51:33+00:00April 13th, 2026|Endpoints News|
The curious case of disappearing polymorphsnews2026-04-13T10:15:00+00:00April 13th, 2026|Chemistry World|
Innovative SMEs and start-ups can be the Change Makers we need to tackle PFASnews2026-04-13T09:30:00+00:00April 13th, 2026|Chemistry World|
